Primary Biliary Cholangitis: Clinical Trials

3 recruiting. 3 Phase 2, 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	3	Recruiting 3
Phase 3	2	Recruiting 2

Follow Primary Biliary Cholangitis: new trials by email Literature Review of Primary Biliary Cholangitis trials Research Report on Primary Biliary Cholangitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study of Seladelpar and Cilofexor in Participants With Primary Biliary Cholangitis Seladelpar, PTM Seladelpar, Cilofexor Dose B - Primary Biliary Cholangitis	Phase 2	Recruiting	Gilead Sciences	132	2026-10-01	2026-10-27
Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis Fenofibrate 200mg, Placebo, UDCA - Primary Biliary Cholangitis	Phase 2 / Phase 3	Recruiting	Xijing Hospital of Digestive Diseases	104	2023-02-17	2026-01-08
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC) Fenofibrate, UDCA - Primary Biliary Cholangitis	Phase 2 / Phase 3	Recruiting	Xijing Hospital of Digestive Diseases	117	2017-04-08	2026-10-30

Narrower conditions

Liver Cirrhosis, Biliary (3)

Broader conditions

Bile Duct Diseases (3)  ·  Biliary Tract Diseases (3)  ·  Cholestasis (3)  ·  Cholestasis, Intrahepatic (3)  ·  Digestive System Diseases (3)  ·  Fibrosis (3)  ·  Liver Cirrhosis (3)  ·  Liver Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)

Interventions

Fenofibrate (2)  ·  seladelpar (1)

Sponsors

Xijing Hospital of Digestive Diseases (2)  ·  Gilead Sciences (1)

Countries

China (2)  ·  United States (1)

Top investigators

Ying Han (1)